Medtronic (NYSE:MDT) announced today that it partnered with Surgical Theater to offer an augmented reality platform for cranial procedures. Fridley, Minn.-based Medtronic will interface its StealthStation S8 surgical navigation system with Surgical Theater’s SyncAR technology to enable neurosurgeons to use AR in real-time to enhance their visualization during complex cranial procedures, according to a news […]
Surgical
Intuitive Surgical must face electrified scissors lawsuit
A U.S. appeals court revived a lawsuit alleging that flawed electrical scissors from Intuitive Surgical were used during a hysterectomy. The appeals court panel ruled that a lower court applied the wrong legal standard in dismissing Tamanchia Moore’s lawsuit against Intuitive. Specifically, the district court erred by excluding Moore’s causation expert, according to the ruling […]
Proximie raises $38M in Series B round
Digital surgery company Proximie this week announced it has raised $38 million in a Series B equity financing round. F-Prime Capital led the round, with participation from new investors Questa Capital, Eight Roads, Maverick Ventures. There was also support from existing investors Global Ventures, BECO Capital and Cedar Mundi Ventures. Proximie’s platform uses augmented reality (AR), machine […]
Titan Medical expands senior leadership team
Titan Medical (TSX:TMD;OTC:TITFX) announced today that it appointed two new members to its senior leadership team. Kristen Galfetti will join as VP of investor relations & corporate communications and will be located in Boston, while Chien Huang as been appointed as VP of finance and will be located in Toronto. Galfetti, a more than 20-year veteran […]
Intuitive Surgical up on Street-beating Q1
Intuitive Surgical (NYSE:ISRG) stock rose nearly 10% today, a day after the company reported first-quarter results that handily beat Wall Street expectations. Baird upgraded Intuitive’s stock rating to outperform after the news yesterday evening, according to media reports. The Sunnyvale, Calif.–based robotic surgery company reported profits of $435.2 million, or $3.51 per share, on sales […]
FDA clears Zimmer Biomet partial knee system for its Rosa system
Zimmer Biomet today said it received FDA 510(k) clearance for its Rosa Partial Knee system for robotically-assisted partial knee replacement surgeries. Rosa Partial Knee is the latest addition to Zimmer Biomet’s Rosa Robotics platform, which includes the Rosa Knee system for total knee replacement surgery and Rosa One for neurosurgical and spine procedures. The Rosa […]
9 medical devices you should keep an eye out for in 2021
The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek approval or […]
SeaSpine prices $87.8M offering
SeaSpine (NSDQ:SPNE) announced that it priced an underwritten public offering worth proceeds of approximately $87.8 million. Carlsbad, Calif.-based SeaSpine is offering 4.5 million shares of its common stock at a public offering price of $19.50 per share, leading to the $87.8 million expected in proceeds before deducting discounts, commissions and other expenses, according to a […]
Vicarious Surgical to go public in $1.1B SPAC deal
Vicarious Surgical will go public through a $1.1 billion special purpose acquisition company (SPAC) deal, the robotic surgery pioneer announced today. Vicarious, which has sought to bring robotics and virtual reality to minimally invasive surgery, will trade on the New York Stock Exchange under the symbol RBOT after the merger with D8 Holdings. Hong Kong–based […]
Innocoll Biotherapeutics initiates Phase 3 trials for collagen drug-device
Innocoll Biotherapeutics announced today that it initiated two Phase 3 trials to support a label expansion for its collagen drug-device implant. Athlone, Ireland–based Innocoll’s trials are seeking label expansion for the FDA-approved Xaracoll (bupivacaine hydrochloride) implant, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
SentiAR closes $5.1M Series A
SentiAR announced today that it closed an oversubscribed Series A financing round that brought in proceeds of $5.1 million. St. Louis-based SentiAR said in a news release that the money will allow it to accelerate the innovation of its mixed reality CommandEP system for surgical visualization. CommandEP is designed to provide physicians with holographic visualization […]